Sylvie Laquerre

4 Patents

• US124484552025

  Combination Therapies with Bispecific Anti-egfr/c-met Antibodies and Third Generation EGFR Tyrosine Kinase Inhibitors

  Janssen Biotech, Inc.

  0 cites
• US122151602025

  Treatment of Patients Having C-met Exon 14 Skipping Mutations

  Janssen Biotech, Inc.

  0 cites
• US118790132024

  Combination Therapies with Bispecific Anti-egfr/c-met Antibodies and Third Generation EGFR Tyrosine Kinase Inhibitors

  JANSSEN BIOTECH, Inc.

  0 cites
• US118277082023

  Proteins Comprising HLA-G Antigen Binding Domains and Their Uses

  Janssen Biotech, Inc.

  0 cites